neurohagana ltd. - preclinical company session - 2024 sci investor symposium
Published 2 weeks ago • 11 plays • Length 16:42
Download video MP4
Download video MP3
Similar videos
-
19:00
novoron bioscience - preclinical company session - 2024 sci investor symposium
-
16:06
acute phase of sci: a surgeon's perspective by richard g. fessler, md, phd
-
20:41
nervgen pharma corp. corporate presentation - 2023 sci investor symposium
-
19:09
lineage cell therapeutics, inc. corporate presentation - 2023 sci investor symposium
-
23:56
onward medical n.v. corporate presentation - 2023 sci investor symposium
-
1:31:51
nervgen291 medicamento p/ reparar o snc, lesão medula, esclerose , alzheimer, lesão cerebral, avc
-
7:42
spinal paralysis research close to human clinical trials
-
7:31
the nervgen origin story
-
18:18
spinal cord outcomes partnership endeavor (scope) presentation - 2023 sci investor symposium
-
1:25:59
discussion panel 2: the future of spinal cord injury clinical trials - 2023 sci investor symposium
-
17:20
cirm presentation - lila collins, phd - 2023 sci investor symposium
-
15:42
2023 sci investor symposium - sci clinical trial landscape by richard g. fessler, md, phd
-
21:24
complexity of clinical trials during acute rehabilitation - steven kirshblum, md
-
1:09:18
"next-gen neural stem cell therapies for spinal cord injury regeneration," dr. ahuja, sep 12, 2024
-
3:54
regenerative medicine: neuro-regenerative therapies | conference preview
-
10:37
reneuron - company presentation
-
5:09
advances in translational chordoma research
Clip.africa.com - Privacy-policy